US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist
  • 12.680
  • -1.070-7.78%
Close Jan 17 16:00 ET
  • 13.170
  • +0.490+3.86%
Post 20:01 ET
1.48BMarket Cap-7.59P/E (TTM)

Arcutis Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arcutis Biotherapeutics Q4 2024 Estimates Date

Currency：USDFeb 25, 2025

Estimate YoY
Revenue
59.09M
+336.85%
EPS
-0.25
+65.05%
Analyst Rating
Strong Buy

Jan 13, 2025

Arcutis Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 60.692M--
Feb 25, 20252024/Q4-- / 59.088M--
Nov 6, 20242024/Q344.755M / 37.340M--
Aug 14, 20242024/Q230.858M / 29.080M--
May 14, 20242024/Q149.569M / 15.140M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 60.692M--
Feb 25, 20252024/Q4-- / 59.088M--
Nov 6, 20242024/Q344.755M / 37.340M--
Aug 14, 20242024/Q230.858M / 29.080M--
May 14, 20242024/Q149.569M / 15.140M--

Unlock Free Earnings Estimates

Arcutis Biotherapeutics Earnings Reports

  • Arcutis Biotherapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6, 2024 16:12 ET

  • Arcutis Biotherapeutics | 8-K: Arcutis Announces Third Quarter 2024 Financial Results and Provides Business Update

    Nov 6, 2024 16:07 ET

  • Arcutis Biotherapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14, 2024 16:18 ET

  • Arcutis Biotherapeutics | 8-K: Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update

    Aug 14, 2024 16:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 13, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data